Lamprogen, Inc.

Lamprogen, Inc. is a corporate entity registered in SAM.gov since May 2, 2012, with its headquarters located in Bothell, Washington. The company appears to be a technology-focused research organization specializing in advanced fluorescent and spectroscopic technologies for biomedical applications. As a for-profit organization, Lamprogen, Inc. has been actively engaged in developing innovative nanotechnology solutions for scientific research, particularly in the domains of imaging, flow cytometry, and molecular diagnostics.

The company has been awarded multiple federal grants from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program, focusing on cutting-edge research in spectral multiplexing technologies. These grants, totaling approximately $850,740, support projects aimed at developing semiconducting polymer dots (PDots) with advanced fluorescence capabilities. Specifically, Lamprogen, Inc. has been working on expanding spectral multiplexing in various scientific domains, including tissue imaging (developing a 56-color panel for deep immunophenotyping), flow cytometry (creating a 75-color PDot panel), and PCR technologies (developing highly multiplexed PCR assays for clinical diagnostics). The research aims to improve resolution in cell subpopulation analysis, enhance diagnostic capabilities, and provide more efficient and cost-effective methods for molecular research and clinical screening. These innovative technologies have potential transformative applications in spatial biology, pathology workflows, and molecular diagnostics.